Table I: Tricuspid valve hemangioma cases reported in the literature
HLHS is a condition in which the left-sided structures (mitral valve, left ventricle, aortic valve, aorta) are rudimentary and inadequate to support the systemic circulation. HLHS has been reported to occur in approximately 0.016 to 0.036% of all live births [9]. It may be associated with an intact atrial septum or atrial septal abnormalities, the latter being crucial for better prognosis after corrective surgery. HLHS with an intact atrial septum is associated with dismal survival even after corrective surgery due to its complex hemodynamics and altered pulmonary physiology [10]. As the brain and head-neck region is supplied by an inconsistent retrograde flow of blood from the PDA into the arch of the aorta, these fetuses usually have microcephaly and neurodevelopmental anomalies due to a chronic hypoxemic state both in-utero and after birth. Early in-utero diagnosis of this condition may help to perform timely interventions that improve survival rates and prevent neurologic sequelae in the survivors. The cause of death in the index case can be attributed to HLHS. The importance of diagnosing this condition either in the antenatal period or at autopsy is to prevent recurrences in subsequent pregnancies, the risk of which is considerably increased [10]. The hemangioma in this case was an associated finding, and may have aggravated the abnormal hemodynamics by causing tricuspid regurgitation in an already compromised heart. SIDS was ruled out in the index case in view of significant findings in the heart. It can be said with considerable conviction that these hemangiomas are not silent, as all except one previously reported case were symptomatic (4- 8). In conclusion, tricuspid valve hemangioma is extremely rare with only six cases previously reported in the literature. The association between tricuspid valve hemangioma and hypoplastic left heart syndrome is unique. The onus is to develop next generation interventional fetal medicine for the management of such cases and to improve the outcome.
1) Rodrigues D, Sá e Melo A, Loureiro M, da Silva AM, Antunes M,
Providência LA. Cardiac tumors in the pediatric age group-case
reports. Rev Port Cardiol. 2005;24:1509-15.
2) Uzun O, Wilson DG, Vujanic GM, Parsons JM, De Giovanni
JV. Cardiac tumours in children. Orphanet J Rare Diseases.
2007;2:11-24.
3) A nderson RH, Smith A, Cook AC. Hypoplasia of the left heart.
Cardiol Young. 2004;14 Suppl 1:13-21.
4) Lapenna E, De Bonis M, Torracca L, La Canna G, DellAntonio
G, Alfieri O. Cavernous hemangioma of the tricuspid valve:
Minimally invasive surgical resection. Ann Thorac Surg.
2003;76:2097-9.
5) Ray R, Rishi A, Venugopal P, Chopra P. Hemangioma of the
tricuspid valve: A report of two cases with review of literature.
Cardiovasc Pathol. 2004;13:120-2.
6) Wong KK, Sandor GG, Sett SS. Isolated haemangioma of the
tricuspid valve. Cardiol Young. 2004;14:324.
7) Cannata A, Russo CF, Merlanti B, Pedrotti P, Moreo A, Botta L,
Martinelli L. Cavernous hemangioma replacing the septal leaflet
of the tricuspid valve. J Card Surg. 2010;25:524-7.
8) Floria M, Guedes A, Buche M, Deperon R, Marchandise B. A
rare primary cardiac tumour: Cavernous hemangioma of the
tricuspid valve. Eur J Echocardiogr. 2011;12:477.